111 related articles for article (PubMed ID: 999566)
1. Sulphonylureas--action and uses.
Ferrier TM
Aust Fam Physician; 1976 Jul; 5(6):865-6. PubMed ID: 999566
[TBL] [Abstract][Full Text] [Related]
2. [Increased cardiovascular risk in patients with type 2 diabetes treated with sulfonylurea?].
Asvold BO; Jonsbu M; Grill V
Tidsskr Nor Laegeforen; 2000 Sep; 120(21):2560-4. PubMed ID: 11070997
[TBL] [Abstract][Full Text] [Related]
3. [Prolonged treatment with glibenclamide in various types of diabetic patient].
Lozano-Castaneda O; Garcia Viveros M; Gomez Peréz FJ; Rull JA
Prensa Med Mex; 1971 Oct; 36(9):451-5. PubMed ID: 5002035
[No Abstract] [Full Text] [Related]
4. [The relatively frequent incidence of severe sulfonylurea-induced hypoglycemia in the last 25 years in Switzerland. Results of 2 surveys in Switzerland in 1969 and 1984].
Berger W; Caduff F; Pasquel M; Rump A
Schweiz Med Wochenschr; 1986 Feb; 116(5):145-51. PubMed ID: 3961464
[TBL] [Abstract][Full Text] [Related]
5. [Oral antidiabetics].
Bäbler M
Schweiz Rundsch Med Prax; 1972 Feb; 61(8):242-6. PubMed ID: 4659095
[No Abstract] [Full Text] [Related]
6. [88 severe incidents of hypoglycemia in patients under treatment with sulfonylurea compounds. Results of a survey throughout Switzerland during 1968 and 1969].
Berger W
Schweiz Med Wochenschr; 1971 Jul; 101(28):1013-22. PubMed ID: 5141777
[No Abstract] [Full Text] [Related]
7. [Incidence and severity of treatment-induced hypoglycemias in diabetics].
Hasslacher C; Wahl P
Dtsch Med Wochenschr; 1971 Nov; 96(46):1787-91. PubMed ID: 5000535
[No Abstract] [Full Text] [Related]
8. Editorial: Oral therapy in diabetes mellitus.
Scoville AB
South Med J; 1974 Jun; 67(6):635-8. PubMed ID: 4208385
[No Abstract] [Full Text] [Related]
9. [Effect of antidiabetic treatment in ischemic heart diseases].
Pogätsa G; Simon J; Koltai MZ; Ballagi-Pordány G; Aranyi Z
Orv Hetil; 1990 Jan; 131(3):119-26. PubMed ID: 2405334
[TBL] [Abstract][Full Text] [Related]
10. [Indications for sulphonylureas].
Carlström S; Persson G
Lakartidningen; 1979 Nov; 76(48):4341-2. PubMed ID: 522565
[No Abstract] [Full Text] [Related]
11. [Adverse effects and interactions of oral antidiabetics].
Czyzyk A; Stryjek-Kamińska D
Pol Tyg Lek; 1980 Nov; 35(45):1757-60. PubMed ID: 7012809
[No Abstract] [Full Text] [Related]
12. Glipizide, a new sulfonylurea in the treatment of diabetes mellitus. Summary of clinical experience in 1064 cases.
Emanueli A; Molari E; Pirola LC; Caputo G
Arzneimittelforschung; 1972 Nov; 22(11):1881-5. PubMed ID: 4267009
[No Abstract] [Full Text] [Related]
13. [Speech disorders--disorientation--hemiparesis].
Sander U
Fortschr Med; 1982 Jul; 100(26):1262-4. PubMed ID: 7118035
[No Abstract] [Full Text] [Related]
14. [Therapeutic trial of a new antidiabetic with vascular action: 1702 SE].
Jaillard J; Warembourg H
Lille Med; 1972 Oct; 17(9):Suppl 6:1332-6. PubMed ID: 4657429
[No Abstract] [Full Text] [Related]
15. Treatment with glibenclamide in maturity-onset diabetes mellitus.
Persson I; Madsen SN
Geriatrics; 1971 May; 26(5):182-95. PubMed ID: 5004113
[No Abstract] [Full Text] [Related]
16. [The risk of hypoglycemia in sulfonylurea therapy].
Berger W; Koller F
Helv Med Acta; 1972 Apr; 36(2):228-9. PubMed ID: 5029101
[No Abstract] [Full Text] [Related]
17. [Hypoglycemia].
Fagulha A
Acta Med Port; 1989 Sep; Suppl 1():25S-26S. PubMed ID: 2694771
[TBL] [Abstract][Full Text] [Related]
18. Modifications of glycemia and insulinemia in diabetics treated with glipizide (K 4024), a new sulfonylurea.
Fedele D; Tiengo A; Riva F; Muggeo M; Emanueli A; Crepaldi G
Arzneimittelforschung; 1972 Nov; 22(11):1885-8. PubMed ID: 4679060
[No Abstract] [Full Text] [Related]
19. [Modern treatment of diabetes mellitus with sulfonylurea compounds].
Haller H; Hanefeld M; Leonhardt W
Z Arztl Fortbild (Jena); 1979 May; 73(10):482-7. PubMed ID: 158261
[No Abstract] [Full Text] [Related]
20. [Clinical trial of glypizide].
Cañadell Vidal J
Rev Iber Endocrinol; 1974 Jan; 21(121):61-73. PubMed ID: 4826383
[No Abstract] [Full Text] [Related]
[Next] [New Search]
